Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerFederico Cappuzzo, Marileila Varella‐Garcia|JNCI Journal of the National Cancer Institute|2005Cited by 1.6k
Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung CancerFred R. Hirsch, Brian R. Holloway, Marileila Varella‐Garcia et al.|Journal of Clinical Oncology|2006Cited by 702
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Pasi A. Jänne, Yong Gon Cho et al.|Science Translational Medicine|2011Cited by 670
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung CancerMatthew P. Smeltzer, Fred R. Hirsch, Murry W. Wynes et al.|Journal of Thoracic Oncology|2020Cited by 184
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional LandscapeZixing Wang, Kanishka Sircar, Tae Beom Kim et al.|Clinical Cancer Research|2017Cited by 94